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Neuromodulators have profound effects on behavior, but the dynamics of their
intracellular effectors has remained unclear. Most neuromodulators exert their function
via G-protein-coupled receptors (GPCRs). One major challenge for understanding
neuromodulator action is the lack of dynamic readouts of the biochemical signals produced
by GPCR activation. The adenylate cyclase/cyclic AMP/protein kinase A (PKA) module is
a central component of such biochemical signaling. This module is regulated by several
behaviorally important neuromodulator receptors. Furthermore, PKA activity is necessary
for the induction of many forms of synaptic plasticity as well as for the formation of
long-term memory. In order to monitor PKA activity in brain tissue, we have developed
a 2-photon ﬂuorescence lifetime imaging microscopy (2pFLIM) compatible PKA sensor
termed FLIM-AKAR, which is based on the ratiometric FRET sensor AKAR3. FLIM-AKAR
shows a large dynamic range and little pH sensitivity. In addition, it is a rapidly diffusible
cytoplasmic protein that speciﬁcally reports net PKA activity in situ. FLIM-AKAR expresses
robustly in various brain regions with multiple transfection methods, can be targeted to
genetically identiﬁed cell types, and responds to activation of both endogenous GPCRs
and spatial-temporally speciﬁc delivery of glutamate. Initial experiments reveal differential
regulation of PKA activity across subcellular compartments in response to neuromodulator
inputs. Therefore, the reporter FLIM-AKAR, coupled with 2pFLIM, enables the study of
PKA activity in response to neuromodulator inputs in genetically identiﬁed neurons in the
brain, and sheds light on the intracellular dynamics of endogenous GPCR activation.
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INTRODUCTION
Neuromodulators such as dopamine, serotonin and opioids have
profound effects on neurons, circuits and behavior (Hikosaka
et al., 2008; Kreitzer and Malenka, 2008; Le Merrer et al., 2009).
Perturbations in neuromodulator function have been linked to
diseases such as Parkinson’s, and neuromodulator therapy has
been used to treat diseases such as depression and schizophrenia
(Albin et al., 1989; Nemeroff and Owens, 2002; Le Merrer et al.,
2009).
Extensive biochemical characterization has identiﬁed protein
kinase A (PKA) as a convergent site of action for many neuro-
modulators and neurotransmitters (Greengard, 2001). Most neu-
romodulatorsexerttheirfunction viaG-protein-coupledreceptor
(GPCRs); neurotransmitters including glutamate and GABA can
also act via metabotropic receptors that are GPCRs. GPCRs cou-
pled to Gαs and Gαi produce up- and down-regulation of adeny-
late cyclase (AC) activity, respectively. Activated AC produces
cAMP whose accumulation activates PKA. Thus, Gαs- and Gαi-
coupled GPCRs bidirectionally change PKA activity (Greengard,
2001). PKA, in turn, modulates synaptic transmission, long-term
plasticity, learning and memory, and has been implicated in a
number of neurodegenerative and psychiatric diseases (Brunelli
et al., 1976; Kandel and Abel, 1995; Davis, 1996; Brandon et al.,
1997; Tzounopoulos et al., 1998; Shaywitz and Greenberg, 1999;
Baxter, 2003; Skeberdis et al., 2006; Tronson et al., 2006; Shen
et al., 2008; Zhong et al., 2009; Higley and Sabatini, 2010).
Therefore, PKA can act as a potential integrator of diverse cellular
inputs to mediate synaptic and cellular changes.
The neurotransmitter and neuromodulator inputs that acti-
vate PKA carry important timing information—for example,
dopamine release in the striatum is thought to modulate glu-
tamatergic synapses that are active near the time of release and
hence reinforce recently executed behaviors (Schultz, 1998; Berke
and Hyman, 2000). In addition, the activity of PKA in different
subcellular compartments, such as dendritic spines, the cyto-
plasm, and the nucleus, phosphorylates different substrates and
triggers different cellular responses. Therefore, in order to under-
stand how PKA dynamically integrates ongoing inputs to affect
cellular and synaptic function, it is necessary to measure both
the timing and subcellular location of PKA activity in response
to endogenous GPCR activation. A Förster Resonance Energy
Transfer (FRET)-based PKA activity reporter, AKAR3, was devel-
oped for ratiometric imaging (Allen and Zhang, 2006). AKAR3
consists of a fusion of a donor ﬂuorophore (truncated CFP),
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a phosphopeptide binding domain (FHA1), a consensus region
of PKA substrates, and an acceptor ﬂuorophore (circularly per-
muted Venus) (Figure 1A). When PKA is inactive, the donor and
acceptor ﬂuorophores are far apart, resulting in low FRET. Upon
phosphorylationbyPKA,thesubstrateregionbindsthephospho-
peptide binding domain FHA1, bringing the donor and acceptor
ﬂuorophores together and resulting in high FRET. Conversely,
dephosphorylation by phosphatases reverses the process. Thus,
AKAR3 serves as a PKA substrate to report the balance between
PKAandphosphatases,whichwehererefertoasnetPKAactivity.
Despite the success of AKAR3 and its derivatives as a ratio-
metric FRET reporter of PKA activity (Allen and Zhang, 2006;
Vincent et al., 2008; Depry et al., 2011; Lam et al., 2012), it
poses challenges for quantifying FRET in brain tissue, notably
the difﬁculty to use AKAR3 with two photon (2p) microscopy.
An alternative to ratiometric imaging for FRET measurement is
Fluorescence Lifetime Imaging Microscopy (FLIM). FLIM only
measures the donor, and not acceptor ﬂuorescence, and the ﬂu-
orescence lifetime of the donor reﬂects the FRET interaction
between the donor and acceptor: increased FRET from donor to
acceptor is directly reﬂected as a reduced ﬂuorescence lifetime
of the donor (Supplementary Figure 1). A FLIM reporter can
potentially alleviate the challenge of 2p ratiometric imaging such
as spectral bleedthrough and wavelength-dependent scattering,
FIGURE 1 | Development of a PKA sensor compatible with 2-photon
Fluorescence Lifetime Imaging Microscopy (2pFLIM). (A) Diagram
illustrating how PKA activity induces FRET in the reporter. Upon
phosophrylation by PKA, the substrate region binds FHA domain, bringing
the donor and acceptor together and resulting in FRET. The phosphorylated
reporter leads to an increase of acceptor:donor emission ratio, as well as a
decrease in donor ﬂuorescence lifetime because of an additional energy
transfer pathway. (B) Schematic of the original PKA reporter AKAR3 (Allen
and Zhang, 2006) and three new PKA reporters.
andallowsustomonitorthespatiotemporaldynamicsofnetPKA
activity in brain tissue.
Here, we report the development of a 2pFLIM compatible
sensor FLIM-AKAR that reports the balance of PKA and phos-
phatase activity. The new reporter shows a large dynamic range,
little pH sensitivity, and is speciﬁc for PKA. In addition, it acts
as a rapidly diffusible cytoplasmic protein. The reporter can be
introduced into neurons via biolistic transfection, in utero elec-
troporation, or viral infection, and can report net PKA activity
in subcellular compartments including the nucleus and dendritic
spines. Furthermore, we engineered a Cre recombinase (Cre)-
dependent FLIM-AKAR plasmid which can be packaged into
adeno–associated viruses (AAV), allowing expression in geneti-
callyidentiﬁedneurons.FLIM-AKARsignalsrobustlyinresponse
to AC activation, endogenous GPCR activation and induction
of long-term potentiation at individual dendritic spines, and it
shows differential kinetics of PKA signaling across subcellular
compartments.Therefore,FLIM-AKAR,combinedwith2pFLIM,
provides an essential tool to quantitatively monitor the intracel-
lular dynamics of signaling of a large class of GPCRs with high
spatial temporal resolution.
RESULTS
GENERATION AND COMPARISON OF CONSTRUCTS FOR 2pFLIM
IMAGING OF NET PKA ACTIVITY
Although AKAR3 and its derivatives were successfully used for
ratiometric imaging of PKA activity (Allen and Zhang, 2006;
Vincent et al., 2008; Depry et al., 2011; Lam et al., 2012), they
are not suitable for imaging in brain tissue with 2pFLIM due
to spectral bleedthrough and the properties of the donor ﬂu-
orophore. Therefore, we changed the donor-acceptor pair of
AKAR3 in order to make a 2pFLIM reporter of PKA activity with
the following characteristics: (1) brighter donor ﬂuorescence to
improve the signal-to-noise ratio; (2) darker acceptor ﬂuores-
cence to minimize contamination into the donor channel; (3)
donor ﬂuorophore withless lifetime rundown; and (4) free donor
ﬂuorophore with lifetime distribution well ﬁt by a single expo-
nential, which makes curve ﬁtting easy so that we can calculate
FRET to free donor ratio (Supplementary Figure 1). The con-
siderations for choosing the donor-acceptor pair are detailed in
Supplementary Table 1.
W em a d et h r e ec o n s t r u c t st om e e tt h ea b o v ec r i t e r i a
(Figure 1B) and determined empirically which gave the best
dynamic range. All of the constructs showed good expression in
HEK293T cells (Figure 2A and data not shown). Following addi-
tion of the AC activator forskolin to drive PKA activity, all of the
constructs showed decreased ﬂuorescence lifetimes and increased
FRET fractions of photons, consistent with higher FRET upon
reporter phosophorylation (Figures2B–D). Subsequent appli-
cation of the PKA inhibitor H89 reversed these changes. Of
the three new reporters, AKAR3.4 showed the largest amplitude
change upon AC activation, as measured by both lifetime changes
( lifetime) (Figure 2E) and changes in the FRET fractions of
photons (Figure 2F).
Since intracellular pH can respond to electrical and biochem-
ical signals in neurons (Berg et al., 2009; Tantama et al., 2011;
Raimondo et al., 2012; Rathje et al., 2013) and can also affect
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FIGURE 2 | AKAR3.4 reports PKA activity with the largest dynamic
range in 2pFLIM measurements. (A) Image showing AKAR3.4 expression
in Human Embryonic Kidney (HEK) cells 1 day after transfection.
(B) Fluorescence decay curves following pulsed excitation. Application of
the adenylate cyclase activator forskolin (50μM) in AKAR3.4-transfected
HEK cells results in faster decay and a decrease in lifetime, whereas
application of the PKA inhibitor H89 (10μM) reverses the decay curve to
baseline. The offset arrival time, the time from the detection of photon
excitation from the laser to the detection of the same pulse from the
photomultiplier tube, is labeled in black, and the actual mean ﬂuorescent
lifetime τ is labeled in red. (C) Lifetime heat map of HEK cells transfected
with AKAR3.4, showing lifetime changes induced by forskolin (FSK, 50μM)
followed by H89 (10μM) treatment. (D) Example plots showing lifetime
responses of the four different reporters to forskolin (50μM, red bar)
followed by H89 (10μM, blue bar) treatment. Experiments were done in
HEK cells transfected with the respective reporters. (E) Amplitudes of
 lifetime between baseline and forskolin (50μM) treatments. (F) Change in
the FRET fraction of photons (PFRET based on the annotation in
Supplementary Figure 1) between baseline and forskolin (50μM)
treatments. For (E,F), n = 12, 10, 14, and 12 cells for AKAR, AKAR3.2,
AKAR3.3, and AKAR3.4 respectively. ∗p < 0.003 when the amplitudes of
the reporter and AKAR3.4 were compared (α = 0.017 for a familywise error
rate of 0.05).
protein ﬂuorescence, we characterized how the different con-
structs responded to changes in pH. To manipulate intracellular
pH, the K+/H+ ionophore nigericin was used to permeabi-
lize the plasma membrane to protons (Thomas et al., 1979),
and extracellular solutions buffered to different pH values were
applied. In addition, the cell-permeable PKA inhibitor H89 was
included to eliminate any potential pH-induced change in PKA
a c t i v i t y .O ft h ef o u rc o n s t r u c t s ,A K A R 3a n dA K A R 3 . 2s h o w e d
large changes with varying pH, whereas AKAR3.3 and AKAR3.4
showed little pH sensitivity (Figure 3). AKAR3.4 contains trun-
cated monomeric eGFP (meGFP ) as the donor and circularly
permuted dark YFP (cpsREACH) as the acceptor. Therefore, in
addition to the largest amplitude of  lifetime in response to
AC activation and little pH sensitivity, AKAR3.4 also fulﬁlled
the criteria outlined above, showing brighter donor ﬂuorescence
(Piston et al.; Shaner et al., 2007), darker acceptor ﬂuorescence
(Ganesan et al., 2006; Murakoshi et al., 2008), and less donor
lifetime rundown than the original AKAR3 (Figure 2D). meGFP
also shows a single exponential decay (Murakoshi et al., 2008),
whereas CFP in AKAR3 shows multi-exponential decay. Thus,
AKAR3.4 is the most suitable PKA activity reporter for quanti-
tative 2pFLIM imaging. We termed it FLIM-AKAR and used it
for the remainder of the study.
DIFFUSION AND SPECIFICITY OF FLIM-AKAR
FLIM-AKAR is a substrate for PKA phosphorylation and is not
targeted to any subcellular compartments. Therefore, in order
to understand if spatial patterns of the FLIM-AKAR response
represent subcellular spatial differences in net PKA activity in real
time, it is necessary to characterize its diffusional properties. To
do so, we performed ﬂuorescence recovery after photobleaching
(FRAP) in CA1 pyramidal neurons to measure the replenishment
of FLIM-AKAR after bleaching (Figures 4A–C). FRAP in aspiny
regions of dendrites revealed a time constant of recovery of
323 ± 42ms (mean ± standard error of the mean (SEM),
n = 16 regions of dendrites, Figure 4E). FRAP in the heads of
mushroom-like spines revealed time constants of recovery of
544 ± 49ms (mean ± SEM, n = 22 spines, Figure 4D). This
is comparable to time constants of diffusional equilibration
across spine head for other diffusible proteins of similar size
(Pologruto et al., 2004; Bloodgood and Sabatini, 2005; Harvey
et al., 2008; Lee et al., 2009; Yasuda and Murakoshi, 2011).
Therefore, we conclude that FLIM-AKAR behaves as a rapidly
diffusible cytoplasmic protein. Thus, if a more persistent lifetime
change is observed in the spine in a given experiment compared
with the diffusion time constant, it is attributable to active PKA
or phosphatase activity in the spine (see below).
Previous versions of AKAR do not respond to CamKII or PKC.
In addition, in the presence of the PKA inhibitor H89 or the PKA
inhibitor peptide (PKI), they do not respond to isoproterenol
activation of the Gαs-coupled β-adrenergic receptors (Zhang
et al., 2001, 2005; Allen and Zhang, 2006), conﬁrming their speci-
ﬁcity for PKA. We also tested the speciﬁcity of FLIM-AKAR to
report changes in net PKA activity. First, we introduced a point
mutation at the phosphorylation site in the substrate region.
This mutant reporter (FLIM-AKART391A) did not respond to
forskolin or H89 application (Figures 5A–C), indicating that this
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FIGURE 3 | AKAR3.4 shows little sensitivity to pH. (A–D) Example plots
showing responses of the four reporters to pH changes. Experiments were
performed in HEK cells at room temperature in the presence of nigericin (5μM)
and the PKA inhibitor H89 (10μM). Extracellular solutions buffered to different
pH values were applied. (E) Summary graph showing  lifetime in response to
different pH in HEK cells.  lifetime was measured relative to that at pH 7 .5.
n = 8, 8, 7 , and 7 cells for AKAR3, AKAR3.2, AKAR3.3, and AKAR3.4
respectively. Graphs show mean and SEMs.
phosphorylatable residue is required for FLIM-AKAR response
to AC activation. Second, FLIM-AKAR did not respond to acti-
vation of PKC by phorbol 12, 13-dibutyrate (PDBu), conﬁrming
that the reporter is not sensitive to PKC activation (n = 9c e l l s ) .
Third, addition of H89 to inhibit PKA largely reversed forskolin-
induced  lifetime (Figures 5B,E). Finally, in the presence of the
PKA inhibitor peptide PKI (Ashby and Walsh, 1972, 1973; Dalton
and Dewey, 2006), FLIM-AKAR did not respond to addition of
forskolin or H89 (Figures5D–F). Taken together, these results
demonstrate that FLIM-AKAR does not respond to PKC, and is
speciﬁc for PKA following AC activation by forskolin.
In vivo EXPRESSION AND RESPONSE TO ENDOGENOUS RECEPTOR
ACTIVATION
We tested if FLIM-AKAR shows sufﬁciently high expression
in vivo and adequate characteristics to report changes in PKA
activity following glutamate or endogenous neuromodulator
receptor activation in thick brain tissue. We introduced FLIM-
AKAR with three different methods into brain tissue. First,
we transfected FLIM-AKAR biolistically in organotypic slices
(Figure 6A). Second, we introduced FLIM-AKAR by in utero
electroporation into the cortex (data not shown) or hippocam-
pus (Figure 6B). Third, we generated an adeno-associated virus
(AAV) that expresses FLIM-AKAR in a Cre-recombinase (Cre)
dependent manner, and injected the virus into mice express-
ing Cre in speciﬁc cell populations (Figures 7A–C). In all three
cases, FLIM-AKAR showed robust expression, and can be seen in
the soma and dendrites, including dendritic spines. Thus, FLIM-
AKAR is a versatile reporter that can be introduced by a variety of
methods to achieve expression in vivo.
In order to test if FLIM-AKAR has the sensitivity to respond
to spatiotemporally precise and physiologically relevant stimuli,
we delivered glutamate by 2-photon photolysis of photoacti-
vatable glutamate (MNI-glutamate) adjacent to individual den-
dritic spines. The stimulated spine enlarged in response to a
structural plasticity protocol previously reported in multiple
studies to induce potentiation of the associated postsynaptic ter-
minal (Matsuzaki et al., 2004; Steiner et al., 2008; Murakoshi
et al., 2011). Strikingly, this resulted in a decrease in ﬂuorescence
lifetime during and after photoactivation to release glutamate
(Figure 6C). Thus, 2-photon photolysis of photoactivatable glu-
tamate leads to a net increase of PKA activity in the stimulated
spine, and FLIM-AKAR can report net PKA activity in small vol-
umes such as the spine in response to spatiotemporally precise
stimuli.
To test if FLM-AKAR can respond to endogenous GPCR
activation, we used isoproterenol to activate the Gαs-coupled
β-adrenergic receptors in hippocampal CA1 pyramidal neu-
rons (Figure 6D). Fluorescence lifetime decreased in both soma
and dendrites, indicating an increase in net PKA activity.
Subsequent application of forskolin resulted in a further life-
time decrease in somatic cytoplasm but not apical dendrites,
indicatingthatisoproterenolinducedmaximalreporterphospho-
rylation in apical dendrites and partial AC activation in somatic
cytoplasm.
Finally, we targeted FLIM-AKAR to genetically deﬁned cell
types and examined FLIM-AKAR response to endogenous GPCR
activation in distinct cell types. For this purpose, we tested FLIM-
AKAR in the striatum, a subcortical brain region that receives a
large number of neuromodulator inputs (Kreitzer and Malenka,
2008;LernerandKreitzer,2011).Inthestriatum,differentneuro-
modulator receptors are preferentially expressed in different types
of striatal spiny projection neurons (SPNs). Indirect pathway
SPNs (iSPNs) preferentially express the Gαs-coupled adenosine
Frontiers in Pharmacology | Neuropharmacology April 2014 | Volume 5 | Article 56 | 4Chen et al. FRET-FLIM sensor for PKA dynamics
FIGURE 4 | FLIM-AKAR shows similar diffusion properties to a rapidly
diffusing cytoplasmic protein. (A–E) Fluorescence Recovery After
Photobleaching (FRAP) experiments to measure the spreading of
FLIM-AKAR. (A) Image of FLIM-AKAR donor ﬂuorescence of a dendritic
region of a hippocampal CA1 neuron cultured in organotypic slices. The
arrowhead shows the spine that was photobleached. The dashed line
shows the region being imaged by line scan. (B) Fluorescence measured in
line scans for the region indicated by dashed line in (A). (C) Quantiﬁcation
of FRAP for the spine shown in (A,B). The trace was an average of 4
acquisitions. The red trace shows curve ﬁtting with a single exponential
decay. (D,E) Cumulative distribution of τ from FRAP experiments to
examine FLIM-AKAR spreading from spines (D) and for aspiny regions of
dendrites (E) in hippocampal CA1 neurons.
receptor A2AR, whereas direct pathway SPNs (dSPNs) prefer-
entially express the Gαs-coupled dopamine D1 receptors (D1R)
(KreitzerandMalenka,2008;LernerandKreitzer,2011).Thus,we
w o u l de x p e c tt h a ta c t i v a t i o no ft h ep r e f e r e n t i a l l ye x p r e s s e dG αs-
coupled receptors would result in net PKA activity in the corre-
spondingtypeofSPNs.Here,weﬁrstinjectedAAVencodingCre-
dependent FLIM-AKAR into the striatum of Adora2a BAC-Cre
mice (Heintz, 2004; Durieux et al., 2009) to target iSPNs. FLIM-
AKAR showed robust expression in the striatum (Figures 7B,C).
Application of the A2AR agonist CGS21680 decreased lifetime
in both the cytoplasm and the nucleus (Figure 7D). We also
used Drd1 BAC-Cre mice (Heintz, 2004; Gong et al., 2007), and
injected virus carrying the Cre-dependent FLIM-AKAR into the
striatum in order to target dSPNs. The D1R agonist SKF81297
produced a rapid lifetime decrease in the cytoplasm and a slower
decrease in the nucleus (Figure 7E). Therefore, FLIM-AKAR can
FIGURE 5 | FLIM-AKAR is speciﬁc for PKA following adenylate cyclase
activation by forskolin. All experiments were performed in HEK cells. Red
line indicates bath application of 50μM forsklin (FSK) and blue line indicates
bath application of 10μM H89. (A) Schematic illustrating introduction of the
point mutation T391A that renders the PKA phosophorylation site of
FLIM-AKAR non-functional. (B) Example plots showing FLIM-AKAR lifetime
response to adenylate cyclase activation by forskolin (red) and subsequent
PKA inhibition by H89 (blue) (top), and the lack of a response from the
non-phosphorylatable point mutant FLIM-AKART391A (bottom). (C)
Summary bar graph showing  lifetime from baseline to forskolin treatment
for FLIM-AKAR (n = 9 cells) and the non-phosphorylatable mutant of
FLIM-AKAR (n = 11 cells). ∗p < 10−5. (D) Schematic illustrating how PKI
inhibits PKA activity. Without PKI, binding of cAMP to the regulatory
subunits of PKA (R) frees the catalytic subunits (C), resulting in activation of
PKA. With PKI, even though cAMP binding to the regulatory subunits
dissociates them from the catalytic subunits, PKI can bind to the catalytic
subunits of PKA and inhibit their activity. (E) Example plot showing
FLIM-AKAR response to adenylate cyclase activation and subsequent PKA
inhibition (top), and the lack of a lifetime response by FLIM-AKAR when it
was co-transfected with PKIα (bottom). (F) Summary bar graph showing
 lifetimes from baseline to forskolin treatment for FLIM-AKAR, in the
absence (n = 18 cells) and presence (n = 10 cells) of PKI. ∗p < 10−9.
be targeted to genetically deﬁned cell types, was able to report
regulation of PKA activity by distinct endogenous GPCR in these
celltypes,andrevealeddifferentialkineticsindifferentsubcellular
compartments.
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FIGURE 6 | FLIM-AKAR shows high expression with different
transfection methods and lifetime responses to glutamate or GPCR
activation in the hippocampus. (A) Images showing a hippocampal CA1
neuron (top), dendrite and spines (bottom) from an organotypic slice
transfected with FLIM-AKAR with biolistic method. (B) Image showing a
300μm acute hippocampal slice expressing FLIM-AKAR in CA1 region after
in utero electroporation. (C) Example plot of lifetime change of FLIM-AKAR
in a stimulated spine in response to photolysis of caged glutamate adjacent
to the spine. A CA1 pyramidal neuron in an organotypic hippocampal slice
was biolistically transfected with FLIM-AKAR, and the stimulated spine
shows enlargement following 2-photon photolysis of caged glutamate
(MNI-glutamate). The temporal window of uncaging is indicated in the red
bar above. (D) Lifetime response of FLIM-AKAR upon isoproterenol (1μM,
ISO) treatment to activate β-adrenergic receptors followed by forskolin
(50μM, FSK) treatment to activate adenylate cyclases. The experiment was
done in acute hippocampal slice expressing FLIM-AKAR in CA1 region after
in utero electroporation.
DISCUSSION
In order to image the spatiotemporal dynamics of net PKA
activity in brain tissue, we developed and characterized a
2pFLIM-compatible PKA reporter FLIM-AKAR for quantitative
imaging. FLIM-AKAR shows a large dynamic range of FLIM
signals and little pH sensitivity. In addition, it is a diffusible cyto-
plasmic protein and shows speciﬁcity to PKA following forskolin
stimulation. Finally, it can be targeted to genetically deﬁned
neurons, and can report net PKA activity in response to both
glutamate and endogenous neuromodulator GPCR activation.
FIGURE 7 | FLIM-AKAR can be targeted to genetically deﬁned cell
types and reports modulation of PKA by endogenous GPCRs in the
striatum. (A) AAV plasmid map showing how Cre recombinase leads to
AKAR3.4 expression. (B–D) A Cre-dependent AAV virus carrying
FLIM-AKAR was delivered to the striatum of an Adora2a BAC-Cre mouse.
(B) Lifetime heat map of an indirect pathway striatal spiny projection neuron
(iSPN) in an acute striatal slice. Following A2AR activation by its agonist
CGS21680, cytoplasmic FLIM-AKAR became rapidly phosphorylated, while
nuclear FLIM-AKAR showed a slower response. (C) A parasagittal brain
section showing FLIM-AKAR expression in the striatum. (D) Example plots
showing modulation of PKA by A2AR in an iSPN. 1μM CGS21680 was used
to activate A2AR. (E) A Cre-dependent AAV virus carrying FLIM-AKAR was
delivered to the striatum of a Drd1 BAC-Cre mouse to target direct pathway
SPNs (dSPNs). Example plots showing modulation of PKA by SKF81297 in
a dSPN. 1μM SKF81297 was used to activate D1R.
Thus, FLIM-AKAR enables the study of PKA activity in response
to neurotransmitter and neuromodulator inputs in genetically
identiﬁed cell types, and promises to shed light on the intracel-
lular dynamics of endogenous GPCR signaling.
A PKA REPORTER FOR 2pFLIM
2pmicroscopyfacilitatesﬂuorescenceimagingwithinlivingtissue
such as the brain due to its diminished sensitivity to light scat-
tering and the restriction of ﬂuorophore excitation to the focus.
However, it poses considerable challenges for ratiometric FRET
imaging. This is mainly because the 2p excitation spectra of many
ﬂuorophoresarebroad,resultinginoverlappingdonorandaccep-
tor excitation and emission spectra, which leads to noisy intensity
measurements since the noise is ampliﬁed during correction for
spectral bleedthrough during ratiometric imaging (Yasuda et al.,
2006).
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2pFLIM is advantageous over ratiometric imaging for FRET
measurement in thick brain tissue (Bastiaens and Squire, 1999;
Yasuda, 2006). Since 2pFLIM directly measures the lifetime of
the donor ﬂuorophore, it is insensitive to many of the tech-
nical challenges that accompany ratiometric FRET imaging in
brain tissue such as ﬂuorophore concentration and wavelength-
dependent light scattering. 2pFLIM is also not sensitive to arti-
facts introduced by low intensity measurements in ratiometric
FRET, notably focus change, tissue movement, and differential
photobleaching. Furthermore, with the use of dark acceptor ﬂuo-
rophores (Ganesan et al., 2006; Murakoshi et al., 2008), 2pFLIM
avoids the propagation of noise due to corrections for spec-
tral bleedthrough and ectopic excitation of ﬂuorophores involved
in ratiometric FRET. Finally, 2pFLIM is inherently quantitative:
donor lifetime analysis directly gives the fractions of ﬂuorophores
that are free and that have undergone FRET. Thus, although the
PKA reporter AKAR3 and two of its derivatives have proven valu-
ableforratiometricFRETimaging(AllenandZhang,2006;Depry
et al., 2011; Lam et al., 2012), a 2pFLIM reporter of PKA activity
offers advantages for the study of endogenous GPCR signaling in
intact brain tissue.
The 2pFLIM compatible reporter FLIM-AKAR shows robust
responsestoneuromodulatorandneurotransmitterreceptoracti-
vation in brain tissue. We found net PKA activity increase with
activation of β-adrenergic receptors in hippocampal CA1 neu-
rons, of A2ARi ni S P N s ,a n do fD 1 Ri nd S P N s ,a l lo fw h i c ha r e
consistent with the Gαs-coupling of these receptors (Lefkowitz,
2007; Lerner and Kreitzer, 2011). Beside neuromodulator recep-
tor activation, FLIM-AKAR also revealed an increase in net PKA
activity in response to glutamate, potentially due to metabotropic
glutamate receptor activation (Wang and Zhuo, 2012). Thus,
based on the characterization of the reporter and its demon-
strated utility in brain tissue, FLIM-AKAR is suitable for studying
how PKA activity responds to endogenous GPCR signaling in the
brain.
For future use of FLIM-AKAR, a couple of points should be
noted. First, we conﬁrmed the speciﬁcity of FLIM-AKAR for PKA
with multiple methods (Figure 5). However, true speciﬁcity of
any reporter has to be demonstrated for each biological applica-
tion and experimental context, since each stimulus may elicit a
different range of intracellular signals. Therefore, similar speci-
ﬁcity tests should be performed for every new stimulus used
in the future. Second, the expression level of a FLIM sensor is
important. Since autoﬂuorescence with a non-uniform lifetime
distribution can contaminate actual signals, sufﬁcient expression
level is required for an accurate measurement of the lifetime of
a sensor. The amount of expression required can be estimated
by simulation of data combined with autoﬂuorescence measure-
ments in the biological system. In the biological experiments
described here, the expression level is sufﬁcient with all three
methods of transfection.
DIFFUSION OF THE 2pFLIM REPORTER AND COMPARTMENTALIZED
NET PKA ACTIVITY
Compartmentalization of intracellular signals is a key feature
of neuronal processing that gives rise to synaptic speciﬁcity,
and allows spatially segregated responses to different types of
signals (Chen and Sabatini, 2012). Differential PKA kinetics has
been demonstrated between cellular membrane, cytoplasm and
nucleus (Dipilato et al., 2004; Allen and Zhang, 2006; Gervasi
et al., 2007). Since FLIM-AKAR is a PKA substrate that is not
speciﬁcally tagged, the diffusibility of the 2pFLIM reporter is
important for interpreting the localization of PKA activity. Using
FRAP we determined that FLIM-AKAR spreads like a diffusible
cytoplasmic protein (Figure 4), with a time constant of hundreds
of milliseconds.
Comparing time constants between FLIM-AKAR diffusion
and biological experiments can reveal true temporal persistence
and spatial compartmentalization of net PKA activity. Following
structural plasticity induction, the lifetime decrease must be
attributable to long-lasting net PKA activity within the spine,
since the time of recovery to baseline lifetime (minutes) is far
longer than the time constant of FLIM-AKAR diffusion from the
spine(hundredsofmilliseconds).Inadditiontothetemporalper-
sistence, we also demonstrate spatial heterogeneity in net PKA
activity, both during basal states, and in the kinetics and ampli-
tudesofresponse to GPCRactivation (Figures 6,7).Thesespatial
differences are due to differential net PKA activity between den-
drites, nucleus and somatic cytoplasm, since the differences per-
sist on the order of minutes. This raises the interesting possibility
that different physiological signals (different types, duration, and
amplitude of stimulus) can change net PKA activity in different
subcellular compartments, resulting in distinct functional conse-
quences. FLIM-AKAR allows future investigations addressing the
types of stimuli that result in net PKA activity changes in speciﬁc
compartments,andtheactivemechanismsthatmaintainnetPKA
activity differences across subcellular compartments.
QUANTIFICATION OF FLIM CHANGES AND RELATIONSHIP TO GPCR
SIGNALING
An important advantage of FLIM is that it is inherently quanti-
tative, such that the ﬁtting of the ﬂuorescence decay curve with a
double-exponential decay function gives the fractions of donor
ﬂuorophores that are free and that have undergone FRET (for
simplicity of notation, the convolution term with instrument
response curve is not included here) (Yasuda, 2006):
F (t) = F0(Pfreee
− t
τfree + PFRETe
− t
τFRET )
where F (t) is the ﬂuorescence over time, F0 is the peak ﬂuores-
cence, τfree and τFRET are ﬂuorescence lifetimes of donors that
are free and that have undergone FRET respectively, and Pfree and
PFRET are the corresponding fractions of these two species. In the
case of the PKA reporter AKAR,
kPKA
[AKAR]  [pAKAR]
kphosphatase
where pAKAR stands for phosphorylated AKAR. If the expres-
sion level of FLIM-AKAR is low, steady state for the reporter can
be achieved at all times. If the expression level is high, steady state
may only be reached when the lifetime reaches a constant value,
and the time course of the reporter lifetime between these con-
stant values may lag the actual kinase or phosphatase activity. At
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steady state,
kPKA [AKAR] = kphosphatase

pAKAR

Rearrangement of the equation gives the following:
[AKAR]

pAKAR
 =
kphosphatase
kPKA
Therefore, knowing the fraction of pAKAR (fpAKAR =
[pAKAR]
[AKAR]+[pAKAR]) would allow for the calculation of
kphosphatase
kPKA .
fpAKAR can be interpolated from the fraction of free donors
in a measurement. If Pfree

experiment

is the fraction of free
donors in a given experiment, Pfree (AKAR) is the fraction of free
donors measured when the reporters are not phosphorylated
(for example, with the PKA inhibitor H89 or with the non-
phosphorylatable mutant of FLIM-AKAR), Pfree

pAKAR

is the
fraction of donors measured when the reporters are completely
phosphorylated (for example, with forskolin, phosphodiesterase
inhibitor and phosphatase inhibitor), then
fpAKAR =
Pfree (AKAR) − Pfree

experiment

Pfree (AKAR) − Pfree

pAKAR

Thus, the fraction of free donors from a given FLIM measure-
ment can give the fraction of pAKAR, which gives the ratio of
kphosphatase
kPKA at steady state. Therefore, 2pFLIM measurement with
FLIM-AKAR gives valuable quantitative information about the
kinetic balance between PKA and phosphatase activity.
Taken together, our 2pFLIM compatible reporter FLIM-AKAR
allowsanalysisofendogenousGPCRsignalinginbraintissue,and
can reveal previously unavailable quantitative information on the
kinetic balance between phosphorylation and dephosphorylation
of PKA substrates. Biologically, the reporter has revealed com-
partmentalization of net PKA activity in the dendrite, somatic
cytoplasm and nucleus. With the multiple advantages of 2pFLIM
imaging, FLIM-AKAR promises to reveal net PKA activity in
response to neuromodulator inputs with high spatial temporal
speciﬁcity.
MATERIALS AND METHODS
DNA CONSTRUCTS
The original pcDNA3-AKAR3 construct was a gift from Jin
Zhang (Johns Hopkins University) (Allen and Zhang, 2006).
AAV-AKAR3 was constructed by subcloning the coding region
of pcDNA3-AKAR3 into the AAV vector AAV-ChR2-mCherry
via EcoRI and BamHI sites. AAV-AKAR3 was used in imag-
ing experiments in this study and referred to as AKAR3.
AKAR3.2 was constructed by gene synthesis of codon-optimized
truncated mTurquoise (Goedhart et al., 2010) (amino acid
1-227) together with part of the linker region between the
donor and acceptor ﬂuorophores, and subcloning of the
synthesized fragment into AKAR3 via BamHI and PpumI
(Genscript). AKAR3.3 was constructed by gene synthesis of
part of the linker region between the donor and accep-
tor ﬂuorophores together with circularly permuted sReaCh
(Murakoshi et al., 2008)( 175sReaCh173), and subcloning of
the synthesized fragment into AKAR3.2 via SgrAI and EcoRI
(Genscript). AKAR3.4 (also called FLIM-AKAR) was con-
structed by PCR ampliﬁcation of truncated meGFP (amino
acid 1-227) from the template GFP-sReaCh (Murakoshi et al.,
2008) (Addgene) followed by recombination-based cloning
with CloneEZ into AKAR3.3 to replace truncated mTurquoise
(Genscript).
For the construction of the Cre-dependent reporter AAV-
FLEX-FLIM-AKAR, the coding region of FLIM-AKAR was
ampliﬁed by PCR and subcloned into AAV-FLEX-Arch-GFP
(Atasoy et al., 2008; Chow et al., 2010) (Addgene Plasmid
22222) to replace Arch-GFP by recombination-based cloning
with CloneEZ (Genscript).
The non-phosphorylatable point mutant AAV-FLEX-FLIM-
AKART391A was made by site-directed mutagenesis of threonine
to alanine at amino acid 391 of the construct AAV-FLEX-FLIM-
AKAR.
For the construction of AAV-FLEX-PKIalpha-IRES-mRuby2,
thecodingregionofmousePKIalpha(GenBankID:NM_008862)
w a sm a d eb yg e n es y n t h e s i s ,f o l l o w e db ys u b c l o n i n go ft h es y n -
thesized fragment into AAV-FLEX-tmeGFP-IRES-nls-mRuby2
via AvrII and BglII (Genscript). AAV-FLEX-tmeGFP-IRES-nls-
mRuby2 was constructed by gene synthesis of IRES-nls-mRuby2
(Lametal.,2012)andsubsequentcloningintoAAV-FLEX-FLIM-
AKAR via XbaI and XhoI (Genscript).
pBS-β-actin Cre was a gift from Susan Dymecki (Harvard
Medical School).
CELL CULTURE AND TRANSFECTION
HEK293T cells were cultured in DMEM (Invitrogen) supple-
mented with 10% FBS (Invitrogen) at 37◦Ci n5 %C O 2.T h e y
were plated on coverslips in 24-well plates and transfected with
plasmids using Lipofectamine 2000 (Invitrogen). Approximately
15–48h after transfection, the cells were imaged in solutions con-
tainingeitherHEPES-basedbuffer(containinginmM:130KCl,1
EGTA, 1 MgCl2,2 5H E P E S ,1 0gl u c o s e ,2 0s u c r o s e ,p Hwi t hK O H
to 7.5 or as speciﬁed in the manuscript), or ACSF (containing in
mM: 127 NaCl, 2.5 KCl, 25 NaHCO3,1 . 2 5N a H 2PO4,2C a C l 2,1
MgCl2, and 25 glucose) with carbogen (95% O2,5 %C O 2).
For data in Figure 5,p B S - β-actin Cre was cotransfected with
AAV-FLEX-FLIM-AKAR, AAV-FLEX-FLIM-AKART391A or AAV-
FLEX-PKIalpha-IRES-mRuby2.
ANIMAL HUSBANDRY
All procedures for animal husbandry and surgery were per-
formed following protocols approved by the Harvard Standing
Committee on Animal Care and in accordance with National
Institutes of Health guidelines.
BRAIN SLICE PREPARATIONS
Organotypic hippocampal slices were cultured from 6 to 8 day
old Spraque Dawley rats (Stoppini et al., 1991). The brain
was dissected and immediately placed in cold dissection media.
Transverse hippocampal slices were cut with 400μm thickness
and placed above a sterile culture insert (Millicell-CM, Millipore)
in 6-well plates containing prewarmed culture media. DNA
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plasmids were biolistically transfected with a Helios Gene Gun
(Biorad) 2 days after culturing. Bullets were made with 60μg
of DNA.
For acute slices, mice were anesthetized with isoﬂurane. For
hippocampal slices, the brain of C57BL/6 mice was rapidly dis-
sected out. Horizontal sections were cut at 300μm thickness
using a Leica VT1000S vibratome (Leica Instruments, Nussloch,
Germany) in cold sucrose cutting solution containing (in mM)
87 NaCl, 25 NaHCO3, 1.25 NaH2PO4 2.5 KCl, 75 sucrose,
25 glucose, 7.5 MgCl2. For striatal slices, mice ﬁrst underwent
intracardiac perfusion with cold ACSF. Coronal or parasagittal
sections were then cut at 300μm thickness in cold choline cut-
ting solution containing (in mM) 25 NaHCO3,1 . 2 5N a H 2PO4,
2.5 KCl, 7 MgCl2, 25 glucose, 1 CaCl2, 110 choline chloride,
11.6 ascorbic acid, and 3.1 pyruvic acid. Slices were transferred
to ACSF after sectioning. The slices were incubated at 34◦Cf o r
10–15min and then kept in ACSF at room temperature. Slices
were then transferred to a microscope chamber and imaging was
performed in perfusing ACSF with a ﬂow rate of 2–4ml/min.
Both cutting and ACSF solutions were constantly bubbled with
carbogen.
In utero ELECTROPORATION
To target hippocampal pyramidal neurons by in utero electro-
poration, glass injection micropipettes were pulled, and the tip
broken to be approximately 60μm in diameter, and beveled at
18◦ (NARISHIGE, Japan). E15 timed-pregnant female C57BL/6
mice (Charles River, MA, United States) were anesthetized
with 2% isoﬂurane. 1–2μlo fD N A( 1 μg/μl) with the dye
FastGreen (0.005%) were injected into the left lateral ventri-
cle. The embryo head was then held with a tweezer with round
plate electrodes (0.5mm diameter) and electric pulses were
delivered ﬁve times per second (50V, 50ms) with the cath-
ode placed at the right cortex and the anode at the left cortex
(CUY21 electroporator, NEPA GENE, Japan). Warm PBS was
dripped onto embryos periodically. The uterus was placed back
into the pregnant mother, and the muscle and the skin were
sutured separately. Pups were housed with the mother until they
were used.
VIRUS PRODUCTION AND STEREOTAXIC VIRAL INJECTIONS
AAV-FLEX-FLIM-AKARwaspackagedasserotype8atUniversity
of North Carolina Gene Therapy Center Virus Core Facility. For
stereotaxic viral injections, P2–4 pups were anesthetized with
isoﬂuorane and placed on a small stereotaxic frame (David Kopf
Instruments). For striatal injections, 1μl of virus (2 × 10∧12
genome copies/ml of AAV-FLEX-FLIM-AKAR) were injected
into the right hemisphere of either an Adora2a BAC-Cre pup
(GENSAT, founder line KG139) to target iSPNs (Heintz, 2004;
Durieux et al., 2009), or a Drd1 BAC-Cre pup (GENSAT, founder
line EY262) to target dSPNs (Heintz, 2004; Gong et al., 2007).
Injection coordinates were approximately lateral 1.5mm from
Bregma, and 2.3mm beneath the skull. The injection was at a
rate of 200nl/min through a UMP3 microsyringe pump (World
Precision Instruments). After injection, pups were returned to
theirhomecagewiththeirmother,andkeptfor16–22daysbefore
being used for experimentation.
TWO-PHOTON IMAGING AND FLUORESCENCE LIFETIME IMAGING
MICROSCOPY
Two-photon imaging was achieved by a custom-built micro-
scope (Carter and Sabatini, 2004) together with a mode-locked
Ti:sappire laser (Chameleon Vision II, 80MHz, Coherent, Santa
Clara, CA). Photons were collected with fast photomultiplier
tubes (PMTs) (H7422-40MOD Hamamatsu). Excitation wave-
lengths of 820, 860, and 920nm were used to excite donor
ﬂuorophores of CFP, Turquoise, and meGFP respectively. On the
emission path, a 700SP ﬁlter (Semrock) was used to ﬁlter off
excitation light. For meGFP imaging, a 565LP dichroic mirror
(Chroma) and 525/50 emission ﬁlter (Semrock) were used. For
CFP and Turquoise imaging, a 520LP dichroic mirror (Semrock)
and 480/40 emission ﬁlter (Chroma) were used.
The custom-written software ScanImage (Pologruto et al.,
2003) was run in Matlab to acquire imaging data. The FLIM data
acquisitionandanalysismodulesweremodiﬁedfromthesoftware
from Ryohei Yasuda (Max Planck Florida Institute). Scan mirror
controlandﬂuorescencesignalacquisitionwereachievedwiththe
dataacquisition(DAQ)boardPCI6110E(NationalInstruments).
An additional DAQ board PCI 6713 (National Instruments) is
used to generate frame and line clocks to synchronize ScanImage
and the FLIM board SPC-150 (Becker and Hickl GmbH).
The epiﬂuorescence PMTs were used for 2pFLIM, and trans-
ﬂuorescence PMTs for regular imaging. Time-domain single
photon counting was used for FLIM and the data were col-
lected in either 64 or 256 time channels. Lifetime decay curve
was constructed by comparing times of laser pulses detected by
photodiode and photon pulses from the fast PMT.
FLUORESCENCE LIFETIME CURVE FITTING AND IMAGE ANALYSIS
Instrument response curve (IRF) for photon spreading was mea-
sured with double harmonic generation of urea crystals. It was
then used to deconvolve the ﬂuorescence decay curve.
FLIM data were processed by ﬁrst determining the offset
arrival time from a full ﬁeld-of-view to increase the accuracy of
ﬁtting, followed by calculation of FRET fractions of photons for
individual regions of interests (ROIs). The processing procedure
w a sa sd e s c r i b e di nYasuda et al. (2006), Harvey et al. (2008),
except that a measured IRF rather than a Gaussian IRF was used
to ﬁt the ﬂuorescence decay curve.
FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING (FRAP)
For FRAP experiments with FLIM-AKAR, 920nm laser was
used to photobleach meGFP. Fluorescence data were collected 1s
before bleaching and then 10s after a step perturbation of bleach-
ing. Laser pulse width (4, 50, or 100ms) and laser power were
adjusted to give30–50%bleaching.Threeto ten acquisitions were
collected for each spine or dendritic region. For FRAP in spines,
mushroom spines were selected; for FRAP in dendrites, relatively
aspiny regions of dendrites (aspiny in a 5.5 ×5.5μms q u a r e )w e r e
selected. Less than 3 spines or dendrites were imaged from each
cell. Linescan was used to achieve good temporal resolution of
FRAP data.
For processing of FRAP data, ﬂuorescence data from
each acquisition was normalized against baseline before
photobleaching. The data were then averaged and ﬁtted with a
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single exponential decay curve (not specifying return to baseline)
to calculate τ.
STATISTICS
Student t-tests (unpaired, assuming unequal variance) were used
to compare different conditions. In cases where various reporters
were compared with AKAR3.4, Bonferroni correction was used to
counteract the problem of multiple comparisons.
2-PHOTON PHOTOLYSIS OF CAGED GLUTAMATE
A second laser was tuned to 720nm for 2-photon photolysis of
caged glutamate. The bath solution consists of 9ml of circulating
ACSF, with no magnesium, 4mM CaCl2, 1μMT T X ,1 0μMD -
serine,200μMTrolox(Sigma),2mMpyruvate,5U/mlglutamic-
pyruvate transaminase (Sigma), and 3.3mM MNI-glutamate
(Tocris). Light power of 75mW at the back aperture of the 60X
(NA1.1) objective was used. Light pulses were delivered at 0.5ms
duration for each pulse, and 40 pulses were delivered in 1min. 2-
photon uncaging was performed adjacent to a spine, and both the
spine morphology and FLIM-AKAR response were monitored.
PHARMACOLOGY
Drugs were applied via bath perfusion, with the ﬁnal concen-
trations in the brackets: forskolin (50μM), H89 (10μM), iso-
proterenol (1μM), CGS21680 (1μM), and SKF81297 (1μM)
were from Tocris Bioscience; nigericin (5μM) was from Sigma.
The speciﬁed concentration of chemicals were either spiked into
the circulating buffer, or premade buffers with the correct drug
concentrations were switched from one to another via a custom-
made solution exchanger.
AUTHOR NOTE
During the preparation of this manuscript, a single-ﬂuorophore
PKA biosensor has been developed that is also 2pFLIM compati-
ble (Bonnot et al., 2014), and future experiments will be needed
to compare the detailed characteristics of our sensor and the
single-ﬂuorophore PKA biosensor.
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Supplementary Figure 1 | Diagram illustrating how FRET changes
ﬂuorescence lifetime. Free donor ﬂuorophores show a single exponential
decay of ﬂuorescence lifetime distribution (green). When donor and
acceptor ﬂuorophores interact via FRET, an additional decay process
occurs, resulting in bi-exponential decay and shorter lifetime (red). Pfree
and PFRET represent the fractions of donors that are free and that have
undergone FRET respectively. Pfree+ PFRET = 1.
Supplementary Table 1 | Optical characteristics of the three donors and
two acceptors used in the 4 PKA reporters. The brightness is relative to
eGFP . The optical characteristics are based on literature (Piston et al.;
Ganesan et al., 2006; Murakoshi et al., 2008) and our own data.
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